chr5-33987949-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014324.6(AMACR):c.*1144A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.03 in 169,432 control chromosomes in the GnomAD database, including 239 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.029 ( 206 hom., cov: 33)
Exomes 𝑓: 0.037 ( 33 hom. )
Consequence
AMACR
NM_014324.6 3_prime_UTR
NM_014324.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.402
Genes affected
AMACR (HGNC:451): (alpha-methylacyl-CoA racemase) This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R)- and (S)-stereoisomers. The conversion to the (S)-stereoisomers is necessary for degradation of these substrates by peroxisomal beta-oxidation. Encoded proteins from this locus localize to both mitochondria and peroxisomes. Mutations in this gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy due to defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also exists between this gene and the upstream neighboring C1QTNF3 (C1q and tumor necrosis factor related protein 3) gene. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 5-33987949-T-C is Benign according to our data. Variant chr5-33987949-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 353237.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.155 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMACR | NM_014324.6 | c.*1144A>G | 3_prime_UTR_variant | 5/5 | ENST00000335606.11 | NP_055139.4 | ||
C1QTNF3-AMACR | NR_037951.1 | n.2649A>G | non_coding_transcript_exon_variant | 9/9 | ||||
AMACR | NM_001167595.2 | c.*359A>G | 3_prime_UTR_variant | 6/6 | NP_001161067.1 | |||
AMACR | NM_203382.3 | c.*1535A>G | 3_prime_UTR_variant | 4/4 | NP_976316.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMACR | ENST00000335606.11 | c.*1144A>G | 3_prime_UTR_variant | 5/5 | 1 | NM_014324.6 | ENSP00000334424 | P1 | ||
AMACR | ENST00000382072.6 | c.*1535A>G | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000371504 |
Frequencies
GnomAD3 genomes AF: 0.0292 AC: 4437AN: 152190Hom.: 199 Cov.: 33
GnomAD3 genomes
AF:
AC:
4437
AN:
152190
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0368 AC: 630AN: 17126Hom.: 33 Cov.: 0 AF XY: 0.0349 AC XY: 301AN XY: 8616
GnomAD4 exome
AF:
AC:
630
AN:
17126
Hom.:
Cov.:
0
AF XY:
AC XY:
301
AN XY:
8616
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0292 AC: 4449AN: 152306Hom.: 206 Cov.: 33 AF XY: 0.0314 AC XY: 2342AN XY: 74482
GnomAD4 genome
AF:
AC:
4449
AN:
152306
Hom.:
Cov.:
33
AF XY:
AC XY:
2342
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
393
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Oculocutaneous albinism Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Alpha-methylacyl-CoA racemase deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at